Simplification of the Diagnosis of Deep Vein Thrombosis (PALLADIO)
Primary Purpose
Deep Venous Thrombosis
Status
Completed
Phase
Phase 3
Locations
Italy
Study Type
Interventional
Intervention
Extensive search for isolated calf DVT
Sponsored by
About this trial
This is an interventional diagnostic trial for Deep Venous Thrombosis focused on measuring Deep vein thrombosis, Ultrasonography, Pulmonary embolism, D-dimer, Pre-test probability
Eligibility Criteria
Inclusion Criteria:
- outpatients with clinically suspected DVT
- signed informed consent
Exclusion Criteria:
- concomitant signs or symptoms of pulmonary embolism
- previous DVT of the affected leg
- referral for superficial vein thrombosis or bilateral DVT
- ongoing or planned anticoagulant therapy
- need for pharmacological thromboprophylaxis (e.g. recent surgery or medical disease)
- inpatient status
- unavailability to follow up
- pregnancy
- age < 18 years
Sites / Locations
- Paolo Prandoni
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Extensive search for isolated calf DVT
Arm Description
As this is a prospective cohort study, for definition there is only 1 arm
Outcomes
Primary Outcome Measures
Safety of withdrawing anticoagulation from patients labeled as not having DVT on the basis of a one-day examination
To assess the rate of symptomatic thromboembolic events occurring up to 3 months after DVT exclusion
Secondary Outcome Measures
The rate of isolated calf vein thrombi
Patients with high PTP and positive D-dimer in spite of negative CUS of the proximal vein system will undergo extensive search for isolated calf vein DVT.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01412242
Brief Title
Simplification of the Diagnosis of Deep Vein Thrombosis
Acronym
PALLADIO
Official Title
Identification of the Optimal Approach to the Ultrasound Diagnosis of Deep Vein Thrombosis of the Lower Extremities in Symptomatic Patients
Study Type
Interventional
2. Study Status
Record Verification Date
January 2015
Overall Recruitment Status
Completed
Study Start Date
March 2011 (undefined)
Primary Completion Date
July 2014 (Actual)
Study Completion Date
September 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Padova
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Prospective cohort study aimed at simplifying the diagnostic approach to symptomatic patients with the clinical suspicion of deep vein thrombosis (DVT) of the lower extremities. All patients will receive a pre-test clinical probability (PTP) and the determination of D-dimer. Patients with low PTP and negative D-dimer will have the diagnosis ruled out. All other patients will undergo compression ultrasonography (CUS) of the proximal vein system. Patients with negative CUS and either low PTP or negative D-dimer will have the diagnosis ruled out, while those with high PTP and positive D-dimer will undergo extensive ultrasound investigation of the calf vein system. All patients in whom the diagnosis of DVT is ruled out will be followed-up prospectively up to three months for documenting the development of symptomatic thromboembolic events.
Detailed Description
All eligible patients will undergo D-dimer measurement and a formal assessment of pre-test clinical probability (PTP) by means of the Wells score. Patients with unlikely PTP and negative D-dimer will have DVT ruled out and will undergo a 3-month clinical follow-up. If at least one of the two tests is positive, patients will undergo CUS of the proximal vein system by investigating at least the common femoral vein at the groin, the superficial femoral vein at the mid thigh and the popliteal vein(s) in the popliteal fossa. A positive CUS will adjudicate proximal DVT. In the case of negative CUS of the proximal vein system, patients with either negative D-dimer or unlikely PTP will have DVT ruled out, and will undergo a 3-month follow up. Only patients with concomitant likely PTP and positive D-dimer will undergo whole-leg ultrasonography with interrogation of the calf veins. A positive test will adjudicate distal DVT. Patients with negative test will undergo a 3-month clinical follow up.
Follow-up. All patients in whom DVT is ruled out will be monitored for 3 months (either by clinical visit or by telephone contact) after the enrolment in the study. Patients with clinical symptoms of DVT or PE during follow-up will undergo objective diagnostic testing (venous ultrasound for suspected DVT and spiral CT-scan or VQ scan for suspected PE). All source documents will be sent out for an independent adjudication. In case of death, PE diagnosis will be adjudicated by means of autopsy, if available. If autopsy is not available, the adjudication of PE-related death will be done based on clinical documentation.
D-dimer. All quantitative D-dimer tests available at each center will be acceptable for the purpose of this study. D-dimer will be considered negative according to the cut-offs provided by manufacturers.
Sample size. The investigators expect that in every 100 symptomatic outpatients DVT will be excluded without the need for objective testing in approximately 30%, while approximately 20% will have a CUS-detected proximal DVT, approximately 15% will have negative CUS and unlikely PTP in spite of positive D-Dimer (no need for further investigation), approximately 15% will have negative CUS and negative D-Dimer in spite of likely PTP (no need for further investigation, and approximately 20% will have negative CUS and both likely PTP and positive D-Dimer (thus requiring interrogation of the calf vein system).
The investigators hypothesize that the incidence of venous thromboembolic events during follow up in patients labeled as not having DVT will not exceed 1% with the application of the proposed algorithm, and that the upper limit of the 95% confidence intervals around this proportion will not exceed 2%. Accordingly, ap proximately 1100 patients should be enroled.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Deep Venous Thrombosis
Keywords
Deep vein thrombosis, Ultrasonography, Pulmonary embolism, D-dimer, Pre-test probability
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
1100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Extensive search for isolated calf DVT
Arm Type
Experimental
Arm Description
As this is a prospective cohort study, for definition there is only 1 arm
Intervention Type
Other
Intervention Name(s)
Extensive search for isolated calf DVT
Intervention Description
Extensive search for isolated calf DVT in patients with negative CUS of the proximal veins who have a high PTP and a positive D-dimer
Primary Outcome Measure Information:
Title
Safety of withdrawing anticoagulation from patients labeled as not having DVT on the basis of a one-day examination
Description
To assess the rate of symptomatic thromboembolic events occurring up to 3 months after DVT exclusion
Time Frame
Up to 3 months
Secondary Outcome Measure Information:
Title
The rate of isolated calf vein thrombi
Description
Patients with high PTP and positive D-dimer in spite of negative CUS of the proximal vein system will undergo extensive search for isolated calf vein DVT.
Time Frame
Up to 1 day
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
outpatients with clinically suspected DVT
signed informed consent
Exclusion Criteria:
concomitant signs or symptoms of pulmonary embolism
previous DVT of the affected leg
referral for superficial vein thrombosis or bilateral DVT
ongoing or planned anticoagulant therapy
need for pharmacological thromboprophylaxis (e.g. recent surgery or medical disease)
inpatient status
unavailability to follow up
pregnancy
age < 18 years
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paolo Prandoni, MD, PhD
Organizational Affiliation
University of Padua, Italy
Official's Role
Study Chair
Facility Information:
Facility Name
Paolo Prandoni
City
Padua
ZIP/Postal Code
35128
Country
Italy
12. IPD Sharing Statement
Citations:
PubMed Identifier
26686257
Citation
Ageno W, Camporese G, Riva N, Iotti M, Bucherini E, Righini M, Kamphuisen PW, Verhamme P, Douketis JD, Tonello C, Prandoni P; PALLADIO Study Investigators. Analysis of an algorithm incorporating limited and whole-leg assessment of the deep venous system in symptomatic outpatients with suspected deep-vein thrombosis (PALLADIO): a prospective, multicentre, cohort study. Lancet Haematol. 2015 Nov;2(11):e474-80. doi: 10.1016/S2352-3026(15)00190-8. Epub 2015 Oct 18.
Results Reference
derived
Learn more about this trial
Simplification of the Diagnosis of Deep Vein Thrombosis
We'll reach out to this number within 24 hrs